Ardelyx, Inc. (ARDX)
6.095
-0.14
(-2.17%)
USD |
NASDAQ |
May 18, 15:40
Ardelyx Total Liabilities (Quarterly) : 355.88M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 83.31B |
| PTC Therapeutics, Inc. | 3.050B |
| Syndax Pharmaceuticals, Inc. | 431.05M |
| Akebia Therapeutics, Inc. | 335.14M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 504.51M |
| Shareholders Equity (Quarterly) | 148.62M |
| Debt to Equity Ratio | 1.401 |
| Current Ratio | 3.485 |
| Net Debt Paydown Yield | -0.74% |